Pharmaceutical products and industry

Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency

Medicinal products for human use

Critical Medicines Act

A Pharmaceutical Strategy for Europe

European Medicines Agency

Clinical trials on medicinal products for human use

Supplementary protection certificate for medicinal products

Medicinal products for human use: prevention of the entry into the legal supply chain of falsified medicinal products

Medicinal products for human use: information on products subject to medical prescription

Compulsory licensing of patents in crisis situations

Medicinal products for human use: transparency of measures regulating the prices and their inclusion in the scope of public health insurance systems

Medicinal products for human use: pharmacovigilance of products

Monitoring and controlling drug precursors

Resolution on a strategic approach to pharmaceuticals in the environment

Innovative Medicines Initiative 2 Joint Undertaking (IMI2 Joint Undertaking)

Medicinal products for human use: pharmacovigilance of products

Medicinal products for human use: fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities

Fees and charges payable to the European Medicines Agency

Medicinal products for human and veterinary use

European Medicines Agency (EMA): location of the seat

Monitoring intra-EU trade in drug precursors

Medicinal products for human and veterinary use: marketing authorisations

Medicinal products for human use: information on products subject to medical prescription

Mobilisation of the European Globalisation Adjustment Fund: redundancies in the pharmaceutical sector in Sweden

Monitoring EU/third country trade in drug precursors

Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland